thought leadership

Supporting the Production of Next-Gen Therapies

“The Vanrx SA25 Aseptic Filling Workcell is a state-of-the-art machine, providing our clients with a high level of sterility assurance and flexibility through an automated handling, filling, and closing process, designed to minimize line losses. If you have a high-value product and require a small-to-moderate batch size, the Vanrx may be the ideal fit for your program.”

- Kevin Gadient
Director, Manufacturing Sciences & Technology 


In October 2017, Emergent BioSolutions acquired the Vanrx® SA25 Aseptic Filling Workcell, which was installed in our Winnipeg site in Manitoba, Canada, in April 2018. This investment strengthens our capabilities in aseptic processing and enhances our capacity to support the drug development and manufacturing of biotherapeutics and vaccines. Within two years of installation, the Winnipeg site received regulatory approval from Health Canada and the FDA for filling commercial products on their machine.

Multiple vial sizes permit filling without the need for change parts and focuses on preserving drug substance. In addition, the integration of a gloveless isolator, which utilizes press-fit vial closures with incorporated stoppers supplied in a pre-sterilized nest, provides additional flexibility to meet your products needs.

Visit the Vanrx® website to discover more about the features and benefits of this cutting-edge technology.

Learn More About Emergent's Drug Product Services



Lyophilized products are on the rise: Here's what you need to know

There has been a steady increase in demand for lyophilized products in recent years. Due in large part to biologic drug...


Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...


Using Viruses to Target Cancer Cells

Innovation in cancer therapeutics is moving at an accelerated pace. Advancements in the development and manufacturing of...